Cargando…

Hydroxychloroquine: Right bundle branch block and QTc prolongation following off label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426389/ http://dx.doi.org/10.1007/s40278-020-82126-y

Ejemplares similares

Hydroxychloroquine: QTc prolongation following off-label-use: case report
Publicado: (2020)

Hydroxychloroquine: QTc-prolongation following an off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc prolongation following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Prolonged QTc interval following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc interval prolonged following off label use: case report
Publicado: (2021)

Hydroxychloroquine: Sinus bradycardia and QTc prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation following off-label use: 2 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation and off label use: 3 case reports.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc prolongation during off-label treatment: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QTc during off label use: case report
Publicado: (2021)

Hydroxychloroquine: Borderline prolongation of QTc interval during off-label treatment: case report
Publicado: (2020)

Case Report: Right Bundle Brunch Block and QTc Prolongation in a Patient with COVID-19 Treated with Hydroxychloroquine
por: Asli, Rosmonaliza, et al.
Publicado: (2020)

Hydroxychloroquine: Non-sustained monomorphic ventricular tachycardia and QTc prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Hydroxychloroquine/lopinavir/ritonavir: Vomiting and QTc-interval prolongation following off-label therapy: 2 case reports
Publicado: (2021)

Hydroxychloroquine: QTc prolongation: case report.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Torsade de pointes, premature atrial contraction and right bundle branch block following off-label use: 4 case reports
Publicado: (2021)

Hydroxychloroquine: Acute kidney injury, prolonged QTC interval and renal phospholipidosis following off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Persistent increase in QTc interval following off-label use: case report
Publicado: (2022)

Chloroquine: QTc prolongation following off-label use: case report
Publicado: (2022)

Hydroxychloroquine: Corrected QT interval prolongation, first degree atrioventricular block and left bundle branch block during an off-label treatment with hydroxychloroquine for COVID-19 pneumonia: 3 case reports
Publicado: (2020)

Hydroxychloroquine: QTc prolongation: 2 case reports
Publicado: (2021)

Atazanavir/ritonavir: QTc prolongation following off-label treatment: case report
Publicado: (2021)

QTc interval evaluation in patients with right bundle branch block or bifascicular blocks
por: Erkapic, Damir, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2021)

QTc evaluation in patients with bundle branch block
por: Bogossian, Harilaos, et al.
Publicado: (2020)

Multiple drugs: Off label use and QTc prolongation: case report
Publicado: (2021)

Multiple drugs: QTc prolongation and off-label use: case report
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine interactions: Corrected QT (QTc) interval prolongation due to pharmacodynamic interaction following off label use: 2 case reports
Publicado: (2021)

Antivirals/fluoroquinolones: Prolongation of QTc interval following off-label use: 9 case reports
Publicado: (2021)

Multiple drugs: QTc interval prolongation following off-label use: 5 case reports
Publicado: (2022)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Hydroxychloroquine: QT interval prolongation following off-label use: case report
Publicado: (2022)

Hydroxychloroquine/lopinavir/ritonavir: Second-degree atrioventricular block (Mobitz II) with left bundle branch block and paroxysmal atrial fibrillation with bradycardia following off label use: case report
Publicado: (2022)

QTc interval measurement in patients with right bundle branch block: A practical method
por: Alizadeh, Abolfath, et al.
Publicado: (2023)

Multiple drug interactions: QTc time prolongation following off-label use: 3 case reports
Publicado: (2022)

Azithromycin/hydroxychloroquine: Prolonged corrected QT following off label use: case report.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_543r3dmosssv8ptolulnlpotkk